name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Danusertib (PHA-739358)

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Danusertib (PHA-739358) in position A03 in plate 1

text: 10 µM Danusertib (PHA-739358)

characteristic: drug

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM SNS-314 Mesylate

status: PUBLIC

characteristic: External Id

text: Netherlands Cancer Institute

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

characteristic: SRA accession

tag: attribute

characteristic: age

text: Bas van Steensel, Division of Gene Regulation, Netherlands Cancer Institute

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM SNS-314 Mesylate in position A04 in plate 1

characteristic: description

text: 10 µM SNS-314 Mesylate

text: patient with chronic myelogenous leukemia (CML)

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

characteristic: sex

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens

characteristic: title

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM JNJ-7706621

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM JNJ-7706621 in position A05 in plate 1

text: 10 µM JNJ-7706621

characteristic: drug

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM CCT129202

characteristic: External Id

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM CCT129202 in position A06 in plate 1

text: 10 µM CCT129202

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM AG-14361

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM AG-14361 in position A07 in plate 1

text: 10 µM AG-14361

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Tubastatin A HCl

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Tubastatin A HCl in position A08 in plate 1

text: 10 µM Tubastatin A HCl

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM CUDC-907

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM CUDC-907 in position A09 in plate 1

text: 10 µM CUDC-907

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM CI994 (Tacedinaline)

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM CI994 (Tacedinaline) in position A10 in plate 1

text: 10 µM CI994 (Tacedinaline)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Entacapone

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Entacapone in position A11 in plate 1

characteristic: description

text: 10 µM Entacapone

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Iniparib (BSI-201)

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Iniparib (BSI-201) in position B02 in plate 1

text: 10 µM Iniparib (BSI-201)

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Mocetinostat (MGCD0103)

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Mocetinostat (MGCD0103) in position B03 in plate 1

text: 10 µM Mocetinostat (MGCD0103)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: title

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Valproic acid sodium salt (Sodium valproate)

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Valproic acid sodium salt (Sodium valproate) in position B04 in plate 1

characteristic: drug

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Ruxolitinib (INCB018424)

characteristic: External Id

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Ruxolitinib (INCB018424) in position B05 in plate 1

text: 10 µM Ruxolitinib (INCB018424)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Hesperadin

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Hesperadin in position B06 in plate 1

text: 10 µM Hesperadin

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM LY2784544

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM LY2784544 in position B07 in plate 1

text: 10 µM LY2784544

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM NVP-BSK805 2HCl

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM NVP-BSK805 2HCl in position B08 in plate 1

text: 10 µM NVP-BSK805 2HCl

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM MK-5108 (VX-689)

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

characteristic: age

text: Bas van Steensel, Division of Gene Regulation, Netherlands Cancer Institute

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM MK-5108 (VX-689) in position B09 in plate 1

text: 10 µM MK-5108 (VX-689)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM RG108

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM RG108 in position B10 in plate 1

characteristic: description

text: 10 µM RG108

text: patient with chronic myelogenous leukemia (CML)

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Sodium Phenylbutyrate

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Sodium Phenylbutyrate in position B11 in plate 1

text: 10 µM Sodium Phenylbutyrate

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM PCI-24781 (Abexinostat)

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM PCI-24781 (Abexinostat) in position C02 in plate 1

text: 10 µM PCI-24781 (Abexinostat)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: title

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM SRT1720

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM SRT1720 in position C03 in plate 1

text: 10 µM SRT1720

characteristic: drug

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM CYC116

characteristic: External Id

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM CYC116 in position C04 in plate 1

text: 10 µM CYC116

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Resveratrol

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Resveratrol in position C05 in plate 1

text: 10 µM Resveratrol

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM EX 527 (Selisistat)

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM EX 527 (Selisistat) in position C06 in plate 1

text: 10 µM EX 527 (Selisistat)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM SGI-1776 free base

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM SGI-1776 free base in position C07 in plate 1

text: 10 µM SGI-1776 free base

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM TG101209

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM TG101209 in position C08 in plate 1

text: 10 µM TG101209

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM M344

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM M344 in position C09 in plate 1

characteristic: description

text: 10 µM M344

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Baricitinib (LY3009104, INCB028050)

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Baricitinib (LY3009104, INCB028050) in position C10 in plate 1

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Tranylcypromine (2-PCPA) HCl

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Tranylcypromine (2-PCPA) HCl in position C11 in plate 1

text: 10 µM Tranylcypromine (2-PCPA) HCl

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: title

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM LAQ824 (Dacinostat)

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM LAQ824 (Dacinostat) in position D02 in plate 1

text: 10 µM LAQ824 (Dacinostat)

characteristic: drug

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM INO-1001

characteristic: External Id

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM INO-1001 in position D03 in plate 1

text: 10 µM INO-1001

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM ENMD-2076

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: Bas van Steensel, Division of Gene Regulation, Netherlands Cancer Institute

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM ENMD-2076 in position D04 in plate 1

text: 10 µM ENMD-2076

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Droxinostat

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Droxinostat in position D05 in plate 1

text: 10 µM Droxinostat

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Azacitidine

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Azacitidine in position D06 in plate 1

text: 10 µM Azacitidine

text: patient with chronic myelogenous leukemia (CML)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM AZ 960

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM AZ 960 in position D07 in plate 1

text: 10 µM AZ 960

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Resminostat

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Resminostat in position D08 in plate 1

characteristic: description

text: 10 µM Resminostat

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM I-BET151 (GSK1210151A)

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM I-BET151 (GSK1210151A) in position D09 in plate 1

text: 10 µM I-BET151 (GSK1210151A)

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM WHI-P154

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM WHI-P154 in position D10 in plate 1

text: 10 µM WHI-P154

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: title

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM 3-Aminobenzamide

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM 3-Aminobenzamide in position D11 in plate 1

text: 10 µM 3-Aminobenzamide

characteristic: drug

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Quisinostat (JNJ-26481585)

characteristic: External Id

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Quisinostat (JNJ-26481585) in position E02 in plate 1

text: 10 µM Quisinostat (JNJ-26481585)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Alisertib (MLN8237)

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Alisertib (MLN8237) in position E03 in plate 1

text: 10 µM Alisertib (MLN8237)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM CUDC-101

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM CUDC-101 in position E04 in plate 1

text: 10 µM CUDC-101

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Aurora A Inhibitor I

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Aurora A Inhibitor I in position E05 in plate 1

text: 10 µM Aurora A Inhibitor I

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM PCI-34051

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM PCI-34051 in position E06 in plate 1

text: 10 µM PCI-34051

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM CYT387

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM CYT387 in position E07 in plate 1

characteristic: description

text: 10 µM CYT387

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM TAK-901

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM TAK-901 in position E08 in plate 1

text: 10 µM TAK-901

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Tofacitinib (CP-690550,Tasocitinib)

text: Netherlands Cancer Institute

text: live

text: Human

text: Bas van Steensel, Division of Gene Regulation, Netherlands Cancer Institute

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Tofacitinib (CP-690550,Tasocitinib) in position E09 in plate 1

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: title

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM PJ34

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM PJ34 in position E10 in plate 1

text: 10 µM PJ34

characteristic: drug

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Procainamide HCl

characteristic: External Id

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Procainamide HCl in position E11 in plate 1

text: 10 µM Procainamide HCl

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Rucaparib (AG-014699,PF-01367338)

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Rucaparib (AG-014699,PF-01367338) in position F02 in plate 1

text: 10 µM Rucaparib (AG-014699,PF-01367338)

text: patient with chronic myelogenous leukemia (CML)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM AT9283

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM AT9283 in position F03 in plate 1

text: 10 µM AT9283

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Decitabine

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Decitabine in position F04 in plate 1

text: 10 µM Decitabine

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM PHA-680632

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM PHA-680632 in position F05 in plate 1

text: 10 µM PHA-680632

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM KW-2449

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM KW-2449 in position F06 in plate 1

characteristic: description

text: 10 µM KW-2449

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Tubacin

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Tubacin in position F07 in plate 1

text: 10 µM Tubacin

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM AMG-900

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM AMG-900 in position F08 in plate 1

text: 10 µM AMG-900

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: title

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM WP1066

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM WP1066 in position F09 in plate 1

text: 10 µM WP1066

characteristic: drug

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM S-Ruxolitinib (INCB018424)

characteristic: External Id

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM S-Ruxolitinib (INCB018424) in position F10 in plate 1

text: 10 µM S-Ruxolitinib (INCB018424)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Tofacitinib (CP-690550) Citrate

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Tofacitinib (CP-690550) Citrate in position F11 in plate 1

text: 10 µM Tofacitinib (CP-690550) Citrate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM MLN8054

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM MLN8054 in position G02 in plate 1

text: 10 µM MLN8054

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM AG-490 (Tyrphostin B42)

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM AG-490 (Tyrphostin B42) in position G03 in plate 1

text: 10 µM AG-490 (Tyrphostin B42)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM PFI-1 (PF-6405761)

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

characteristic: age

text: Bas van Steensel, Division of Gene Regulation, Netherlands Cancer Institute

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM PFI-1 (PF-6405761) in position G04 in plate 1

text: 10 µM PFI-1 (PF-6405761)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM MC1568

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM MC1568 in position G05 in plate 1

characteristic: description

text: 10 µM MC1568

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM AZD1480

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM AZD1480 in position G06 in plate 1

text: 10 µM AZD1480

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM AR-42

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM AR-42 in position G07 in plate 1

text: 10 µM AR-42

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: title

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM TG101348 (SAR302503)

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM TG101348 (SAR302503) in position G08 in plate 1

text: 10 µM TG101348 (SAR302503)

characteristic: drug

text: patient with chronic myelogenous leukemia (CML)

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Sirtinol

characteristic: External Id

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Sirtinol in position G09 in plate 1

text: 10 µM Sirtinol

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM IOX2

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM IOX2 in position G10 in plate 1

text: 10 µM IOX2

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM AZD2461

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM AZD2461 in position G11 in plate 1

text: 10 µM AZD2461

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM ZM 447439

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM ZM 447439 in position H02 in plate 1

text: 10 µM ZM 447439

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Barasertib (AZD1152-HQPA)

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Barasertib (AZD1152-HQPA) in position H03 in plate 1

text: 10 µM Barasertib (AZD1152-HQPA)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM 2-Methoxyestradiol (2-MeOE2)

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM 2-Methoxyestradiol (2-MeOE2) in position H04 in plate 1

characteristic: description

text: 10 µM 2-Methoxyestradiol (2-MeOE2)

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Pracinostat (SB939)

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Pracinostat (SB939) in position H05 in plate 1

text: 10 µM Pracinostat (SB939)

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Givinostat (ITF2357)

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Givinostat (ITF2357) in position H06 in plate 1

text: 10 µM Givinostat (ITF2357)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: title

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Quercetin

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Quercetin in position H07 in plate 1

text: 10 µM Quercetin

characteristic: drug

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM CCT137690

characteristic: External Id

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM CCT137690 in position H08 in plate 1

text: 10 µM CCT137690

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM CEP-33779

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: Bas van Steensel, Division of Gene Regulation, Netherlands Cancer Institute

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM CEP-33779 in position H09 in plate 1

text: 10 µM CEP-33779

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Romidepsin (FK228, Depsipeptide)

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Romidepsin (FK228, Depsipeptide) in position H10 in plate 1

text: 10 µM Romidepsin (FK228, Depsipeptide)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM XL019

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM XL019 in position H11 in plate 1

text: 10 µM XL019

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Zebularine

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Zebularine in position A02 in plate 2

text: 10 µM Zebularine

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM OG-L002

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM OG-L002 in position A03 in plate 2

characteristic: description

text: 10 µM OG-L002

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM TMP269

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM TMP269 in position A04 in plate 2

text: 10 µM TMP269

text: patient with chronic myelogenous leukemia (CML)

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM ZM 39923 HCl

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM ZM 39923 HCl in position A05 in plate 2

text: 10 µM ZM 39923 HCl

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: title

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Veliparib (ABT-888)

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Veliparib (ABT-888) in position A06 in plate 2

text: 10 µM Veliparib (ABT-888)

characteristic: drug

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM CX-6258 HCl

characteristic: External Id

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM CX-6258 HCl in position A07 in plate 2

text: 10 µM CX-6258 HCl

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM 2,4-Pyridinedicarboxylic Acid

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM 2,4-Pyridinedicarboxylic Acid in position A08 in plate 2

text: 10 µM 2,4-Pyridinedicarboxylic Acid

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM ITSA-1

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM ITSA-1 in position A09 in plate 2

text: 10 µM ITSA-1

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM AGK2

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM AGK2 in position A10 in plate 2

text: 10 µM AGK2

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Oxamflatin

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Oxamflatin in position A11 in plate 2

text: 10 µM Oxamflatin

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM 3-Deazaneplanocin A (DZNeP)

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM 3-Deazaneplanocin A (DZNeP) in position B02 in plate 2

characteristic: description

text: 10 µM 3-Deazaneplanocin A (DZNeP)

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM SGC-CBP30

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM SGC-CBP30 in position B03 in plate 2

text: 10 µM SGC-CBP30

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM EPZ004777

text: Netherlands Cancer Institute

text: live

text: Human

text: Bas van Steensel, Division of Gene Regulation, Netherlands Cancer Institute

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM EPZ004777 in position B04 in plate 2

text: 10 µM EPZ004777

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: title

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM SMI-4a

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM SMI-4a in position B05 in plate 2

text: 10 µM SMI-4a

characteristic: drug

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM FG-4592

characteristic: External Id

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM FG-4592 in position B06 in plate 2

text: 10 µM FG-4592

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM BMN 673

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM BMN 673 in position B07 in plate 2

text: 10 µM BMN 673

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Garcinol

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Garcinol in position B08 in plate 2

text: 10 µM Garcinol

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Tranylcypromine hemisulfate

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Tranylcypromine hemisulfate in position B09 in plate 2

text: 10 µM Tranylcypromine hemisulfate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Salermide

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Salermide in position B10 in plate 2

text: 10 µM Salermide

text: patient with chronic myelogenous leukemia (CML)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Suramin 6Na

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Suramin·6Na in position B11 in plate 2

characteristic: description

text: 10 µM Suramin·6Na

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM EPZ-6438

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM EPZ-6438 in position C02 in plate 2

text: 10 µM EPZ-6438

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM MM-102

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM MM-102 in position C03 in plate 2

text: 10 µM MM-102

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: title

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM OTX015

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM OTX015 in position C04 in plate 2

text: 10 µM OTX015

characteristic: drug

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM BIX 01294

characteristic: External Id

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM BIX 01294 in position C05 in plate 2

text: 10 µM BIX 01294

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Panobinostat (LBH589)

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Panobinostat (LBH589) in position C06 in plate 2

text: 10 µM Panobinostat (LBH589)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM EPZ5676

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM EPZ5676 in position C07 in plate 2

text: 10 µM EPZ5676

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Splitomicin

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Splitomicin in position C08 in plate 2

text: 10 µM Splitomicin

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Valproic acid

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

characteristic: age

text: Bas van Steensel, Division of Gene Regulation, Netherlands Cancer Institute

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Valproic acid in position C09 in plate 2

text: 10 µM Valproic acid

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM MC-1293

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM MC-1293 in position C10 in plate 2

characteristic: description

text: 10 µM MC-1293

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM BML-278

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM BML-278 in position C11 in plate 2

text: 10 µM BML-278

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM C646

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM C646 in position D02 in plate 2

text: 10 µM C646

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: title

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM SGI-1027

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM SGI-1027 in position D03 in plate 2

text: 10 µM SGI-1027

characteristic: drug

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM UNC669

characteristic: External Id

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM UNC669 in position D04 in plate 2

text: 10 µM UNC669

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM UPF 1069

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM UPF 1069 in position D05 in plate 2

text: 10 µM UPF 1069

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Trichostatin A (TSA)

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Trichostatin A (TSA) in position D06 in plate 2

text: 10 µM Trichostatin A (TSA)

text: patient with chronic myelogenous leukemia (CML)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM GSK J4 HCl

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM GSK J4 HCl in position D07 in plate 2

text: 10 µM GSK J4 HCl

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM BML-210

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM BML-210 in position D08 in plate 2

text: 10 µM BML-210

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Nicotinamide

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Nicotinamide in position D09 in plate 2

characteristic: description

text: 10 µM Nicotinamide

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Anacardic acid

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Anacardic acid in position D10 in plate 2

text: 10 µM Anacardic acid

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM NCH-51

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM NCH-51 in position D11 in plate 2

text: 10 µM NCH-51

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: title

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM I-BET-762

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM I-BET-762 in position E02 in plate 2

text: 10 µM I-BET-762

characteristic: drug

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM RG2833 (RGFP109)

characteristic: External Id

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM RG2833 (RGFP109) in position E03 in plate 2

text: 10 µM RG2833 (RGFP109)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM ME0328

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: Bas van Steensel, Division of Gene Regulation, Netherlands Cancer Institute

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM ME0328 in position E04 in plate 2

text: 10 µM ME0328

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Scriptaid

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Scriptaid in position E05 in plate 2

text: 10 µM Scriptaid

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Vorinostat (SAHA, MK0683)

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Vorinostat (SAHA, MK0683) in position E06 in plate 2

text: 10 µM Vorinostat (SAHA, MK0683)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM SGC 0946

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM SGC 0946 in position E07 in plate 2

text: 10 µM SGC 0946

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Apicidin

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Apicidin in position E08 in plate 2

characteristic: description

text: 10 µM Apicidin

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM BML-266

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM BML-266 in position E09 in plate 2

text: 10 µM BML-266

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM B2

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM B2 in position E10 in plate 2

text: 10 µM B2

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: title

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM NSC-3852

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM NSC-3852 in position E11 in plate 2

text: 10 µM NSC-3852

characteristic: drug

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM RGFP966

characteristic: External Id

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM RGFP966 in position F02 in plate 2

text: 10 µM RGFP966

text: patient with chronic myelogenous leukemia (CML)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM RVX-208

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM RVX-208 in position F03 in plate 2

text: 10 µM RVX-208

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Nexturastat A

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Nexturastat A in position F04 in plate 2

text: 10 µM Nexturastat A

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Tubastatin A

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Tubastatin A in position F05 in plate 2

text: 10 µM Tubastatin A

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM VX-680 (Tozasertib, MK-0457)

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM VX-680 (Tozasertib, MK-0457) in position F06 in plate 2

text: 10 µM VX-680 (Tozasertib, MK-0457)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM UNC1215

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM UNC1215 in position F07 in plate 2

characteristic: description

text: 10 µM UNC1215

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Suberoyl bis-hydroxamic acid

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Suberoyl bis-hydroxamic acid in position F08 in plate 2

text: 10 µM Suberoyl bis-hydroxamic acid

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Piceatannol

text: Netherlands Cancer Institute

text: live

text: Human

text: Bas van Steensel, Division of Gene Regulation, Netherlands Cancer Institute

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Piceatannol in position F09 in plate 2

text: 10 µM Piceatannol

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: title

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM BIX-01294 3HCl

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM BIX-01294·3HCl in position F10 in plate 2

text: 10 µM BIX-01294·3HCl

characteristic: drug

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Aminoresveratrol sulfate

characteristic: External Id

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Aminoresveratrol sulfate in position F11 in plate 2

text: 10 µM Aminoresveratrol sulfate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Bromosporine

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Bromosporine in position G02 in plate 2

text: 10 µM Bromosporine

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM PJ34 HCl

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM PJ34 HCl in position G03 in plate 2

text: 10 µM PJ34 HCl

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Filgotinib (GLPG0634)

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Filgotinib (GLPG0634) in position G04 in plate 2

text: 10 µM Filgotinib (GLPG0634)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Lomeguatrib

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Lomeguatrib in position G05 in plate 2

text: 10 µM Lomeguatrib

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Entinostat (MS-275)

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Entinostat (MS-275) in position G06 in plate 2

characteristic: description

text: 10 µM Entinostat (MS-275)

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM AZD1208

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM AZD1208 in position G07 in plate 2

text: 10 µM AZD1208

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Nullscript

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Nullscript in position G08 in plate 2

text: 10 µM Nullscript

text: patient with chronic myelogenous leukemia (CML)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: title

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Fluoro-SAHA

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Fluoro-SAHA in position G09 in plate 2

text: 10 µM Fluoro-SAHA

characteristic: drug

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Butyrolactone 3

characteristic: External Id

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Butyrolactone 3 in position G10 in plate 2

text: 10 µM Butyrolactone 3

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM BML-281

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM BML-281 in position G11 in plate 2

text: 10 µM BML-281

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM IOX1

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM IOX1 in position H02 in plate 2

text: 10 µM IOX1

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM CPI-203

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM CPI-203 in position H03 in plate 2

text: 10 µM CPI-203

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Rocilinostat (ACY-1215)

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

characteristic: age

text: Bas van Steensel, Division of Gene Regulation, Netherlands Cancer Institute

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Rocilinostat (ACY-1215) in position H04 in plate 2

text: 10 µM Rocilinostat (ACY-1215)

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Pacritinib (SB1518)

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Pacritinib (SB1518) in position H05 in plate 2

characteristic: description

text: 10 µM Pacritinib (SB1518)

text: Homo sapiens

characteristic: organism

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Olaparib (AZD2281, Ku-0059436)

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Olaparib (AZD2281, Ku-0059436) in position H06 in plate 2

text: 10 µM Olaparib (AZD2281, Ku-0059436)

text: Homo sapiens

text: cell culture

text: female

characteristic: sex

text: bone marrow

characteristic: tissue

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM (+)-JQ1

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM (+)-JQ1 in position H07 in plate 2

text: 10 µM (+)-JQ1

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens

characteristic: title

characteristic: transfected plasmid


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Isonicotinamide

text: Netherlands Cancer Institute

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Isonicotinamide in position H08 in plate 2

text: 10 µM Isonicotinamide

characteristic: drug

characteristic: isolate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Valproic acid hydroxamate

characteristic: External Id

text: Netherlands Cancer Institute

characteristic: INSDC center name

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Valproic acid hydroxamate in position H09 in plate 2

text: 10 µM Valproic acid hydroxamate

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM CTPB

text: Netherlands Cancer Institute

characteristic: INSDC first public

characteristic: INSDC last update

text: live

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM CTPB in position H10 in plate 2

text: 10 µM CTPB

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 clone5 treated with 10 uM Triacetylresveratrol

text: Netherlands Cancer Institute

characteristic: INSDC secondary accession

text: live

characteristic: INSDC status

text: Human

text: K562-17 ddCas9 DSB-TRIP (RSTP2) clone 5

text: Chronic Myeloid Leukemia

text: Sample from drug screen treated with 10 µM Triacetylresveratrol in position H11 in plate 2

text: 10 µM Triacetylresveratrol

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 pools treated with DMSO

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: NCBI submission model

characteristic: NCBI submission package

text: K562-17 ddCas9 DSB-TRIP (RSTP2) pools

text: Chronic Myeloid Leukemia

text: Sample from drug screen in position treated with DMSO

text: DMSO

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


name: K562 ddCas9 RSTP2 pools treated with Vorinostat

text: Netherlands Cancer Institute

text: live

text: Human

characteristic: SRA accession

characteristic: age

text: K562-17 ddCas9 DSB-TRIP (RSTP2) pools

text: Chronic Myeloid Leukemia

text: Sample from drug screen in position treated with Vorinostat

text: Vorinostat

text: Homo sapiens

text: cell culture

text: female

text: bone marrow

text: Human sample from Homo sapiens


Vagococcus fluvialis

text: Chongqing University Jiangjin Hospital, Chongqing, P. R. China

text: live

text: Microbe, viral or environmental

text: Yuhang Jiang

text: China:Chongqing

text: Homo sapiens

characteristic: host

text: Wound secretion

text: Vagococcus fluvialis

characteristic: organism

text: bacteria strain

text: Microbe sample from Vagococcus fluvialis


text: BGU

text: live

text: Metagenome or environmental

text: replicate 1

characteristic: biosample attribute

text: Israel: Southern District Hadarom, Azgad Stream

text: soil crust

text: bottom of stream

text: 31.08 N 35.25 E

text: soil metagenome

text: Metagenome or environmental sample from soil metagenome


text: BGU

text: live

text: Metagenome or environmental

text: replicate 2

text: soil crust

text: bottom of stream rep

text: 31.08 N 35.25 E

text: soil metagenome

characteristic: title


text: BGU

text: live

text: Metagenome or environmental

text: replicate 1

text: soil crust

text: organic

text: 31.08 N 35.25 E

text: soil metagenome


text: BGU

text: live

text: Metagenome or environmental

text: replicate 2

text: soil crust

text: organic rep

text: 31.08 N 35.25 E

text: soil metagenome


text: BGU

text: live

text: Metagenome or environmental

text: replicate 1

text: soil crust

text: natural

text: 31.08 N 35.25 E

text: soil metagenome


text: BGU

text: live

text: Metagenome or environmental

text: replicate 2

text: soil crust

text: natural rep

text: 31.08 N 35.25 E

text: soil metagenome


text: BGU

text: live

text: Metagenome or environmental

text: replicate 1

text: Israel: Southern District Hadarom, Ashalim 1 Stream

text: soil crust

text: bottom of stream

text: 31.08 N 35.25 E

text: soil metagenome


text: BGU

text: live

text: Metagenome or environmental

text: replicate 2

text: soil crust

text: bottom of stream rep

text: 31.08 N 35.25 E

text: soil metagenome


text: BGU

text: live

text: Metagenome or environmental

text: replicate 1

text: soil crust

text: dark

text: 31.08 N 35.25 E

text: soil metagenome


text: BGU

text: live

text: Metagenome or environmental

text: replicate 2

text: soil crust

text: dark rep

text: 31.08 N 35.25 E

text: soil metagenome


text: BGU

text: live

text: Metagenome or environmental

text: replicate 1

text: soil crust

text: light

text: 31.08 N 35.25 E

text: soil metagenome


text: BGU

text: live

text: Metagenome or environmental

text: replicate 2

text: soil crust

text: light rep

text: 31.08 N 35.25 E

text: soil metagenome


text: BGU

text: live

text: Metagenome or environmental

text: replicate 1

text: soil crust

text: organic

text: 31.08 N 35.25 E

text: soil metagenome


text: BGU

text: live

text: Metagenome or environmental

text: replicate 2

text: soil crust

text: organic rep

text: 31.08 N 35.25 E

text: soil metagenome


text: BGU

text: live

text: Metagenome or environmental

text: replicate 1

text: soil crust

text: natural

text: 31.08 N 35.25 E

text: soil metagenome


text: BGU

text: live

text: Metagenome or environmental

text: replicate 2

text: soil crust

text: natural rep

text: 31.08 N 35.25 E

text: soil metagenome


text: BGU

text: live

text: Metagenome or environmental

text: replicate 1

text: Israel: Southern District Hadarom, Ashalim 2 Stream

text: soil crust

text: bottom of stream

text: 31.08 N 35.25 E

text: soil metagenome


text: BGU

text: live

text: Metagenome or environmental

text: replicate 2

text: soil crust

text: bottom of stream rep

text: 31.08 N 35.25 E

text: soil metagenome


text: BGU

text: live

text: Metagenome or environmental

text: replicate 1

text: soil crust

text: dark

text: 31.08 N 35.25 E

text: soil metagenome


text: BGU

text: live

text: Metagenome or environmental

text: replicate 2

text: soil crust

text: dark rep

text: 31.08 N 35.25 E

text: soil metagenome


text: BGU

text: live

text: Metagenome or environmental

text: replicate 1

text: soil crust

text: light

text: 31.08 N 35.25 E

text: soil metagenome


text: BGU

text: live

text: Metagenome or environmental

text: replicate 2

text: soil crust

text: light rep

text: 31.08 N 35.25 E

text: soil metagenome


text: BGU

text: live

text: Metagenome or environmental

text: replicate 1

text: soil crust

text: organic

text: 31.08 N 35.25 E

text: soil metagenome


text: BGU

text: live

text: Metagenome or environmental

text: replicate 2

text: soil crust

text: organic rep

text: 31.08 N 35.25 E

text: soil metagenome


text: BGU

text: live

text: Metagenome or environmental

text: replicate 1

text: soil crust

text: natural

text: 31.08 N 35.25 E

text: soil metagenome


text: BGU

text: live

text: Metagenome or environmental

text: replicate 2

text: soil crust

text: natural rep

text: 31.08 N 35.25 E

text: soil metagenome


text: Southwest University

text: live

text: MIGS/MIMS/MIMARKS.miscellaneous

text: MIMARKS.survey

text: Keywords: GSC:MIxS;MIMARKS:6.0

characteristic: description

text: colon

text: China: Chongqing

text: pig

text: pig gut metagenome

text: MIMARKS Survey related sample from pig gut metagenome


text: Amity University Uttar Pradesh

text: live

text: Human

text: Adult

text: ATCC

text: Human hepatocyte cell line, THLE2

text: Homo sapiens

text: male

characteristic: sex

text: Liver

characteristic: tissue

text: Human normal liver epithelial cell line


characteristic: External Id

text: Amity University Uttar Pradesh

text: live

text: Human

text: Adult

text: ATCC

text: Human hepatocyte cell line, THLE2

characteristic: isolate

text: Homo sapiens

text: male

text: Liver

text: Human sample from Homo sapiens


text: Amity University Uttar Pradesh

characteristic: INSDC center name

characteristic: INSDC first public

text: live

text: Human

text: Adult

text: ATCC

text: Human hepatocyte cell line, THLE2

text: Homo sapiens

text: male

text: Liver

text: Human normal liver epithelial cell line


Sanghuangporus sanghuang SH1

text: Yunnan Academy of Forestry and Grassland

characteristic: INSDC last update

text: live

text: Microbe, viral or environmental

text: Morus alba

text: Sanghuangporus sanghuang

text: whole organism

characteristic: strain

text: Microbe sample from Sanghuangporus sanghuang


Genome MG1388

text: Toulouse Biotechnology Institute

text: live

characteristic: INSDC status

text: Microbe, viral or environmental

characteristic: NCBI submission model

text: Netherlands

text: dairy starter

text: Lactococcus cremoris

text: cell culture

text: Microbe sample from Lactococcus cremoris


Genome S170

text: Toulouse Biotechnology Institute

text: live

text: Microbe, viral or environmental

characteristic: NCBI submission package

text: France

text: dairy starter

text: Lactococcus lactis

text: cell culture

text: Microbe sample from Lactococcus lactis


Genome CIRM-BIA_1564

text: Toulouse Biotechnology Institute

text: live

text: Microbe, viral or environmental

text: Egypt

text: Cheese (Domiati)

text: Lactococcus cremoris

text: cell culture


text: Ecker lab, Genomic Analysis Laboratory, HHMI-Salk-Institute

characteristic: INSDC secondary accession

text: live

text: Generic

characteristic: SRA accession

characteristic: age

characteristic: brain region

text: Mus musculus

text: C57BL/6J Male P56 Mouse Brain


text: live

text: Generic

text: Mus musculus

characteristic: organism

text: C57BL/6J Male P56 Mouse Brain

characteristic: title


text: Guangxi university

text: live

text: Metagenome or environmental

characteristic: data

text: soil metagenome


text: Guangxi university

text: live

text: Metagenome or environmental

text: soil metagenome


text: Tongji Medical College Huazhong University of Science & Technology

text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: degraded

characteristic: description

text: China:Wuhan

text: blood

text: Homo sapiens

text: MIGS Eukaryotic sample from Homo sapiens


characteristic: External Id

text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: multi-person

text: China:Wuhan

text: blood

text: Homo sapiens


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: two-person (pilot_study)

text: China:Wuhan

text: blood

text: Homo sapiens

text: two-person_1 (pilot_study)


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: two-person (pilot_study)

text: China:Wuhan

text: blood

text: Homo sapiens

text: two-person_2 (pilot_study)


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: two-person (pilot_study)

text: China:Wuhan

text: blood

text: Homo sapiens

text: two-person_3 (pilot_study)


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: two-person (pilot_study)

text: China:Wuhan

text: blood

text: Homo sapiens

text: two-person_4 (pilot_study)


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: two-person (pilot_study)

text: China:Wuhan

text: blood

text: Homo sapiens

text: two-person_5 (pilot_study)


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: two-person (pilot_study)

text: China:Wuhan

text: blood

text: Homo sapiens

text: two-person_6 (pilot_study)


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: two-person (pilot_study)

text: China:Wuhan

text: blood

text: Homo sapiens

text: two-person_7 (pilot_study)


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: two-person (pilot_study)

text: China:Wuhan

text: blood

text: Homo sapiens

text: two-person_8 (pilot_study)


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: two-person (pilot_study)

text: China:Wuhan

text: blood

text: Homo sapiens

text: two-person_9 (pilot_study)


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: two-person (pilot_study)

text: China:Wuhan

text: blood

text: Homo sapiens

text: two-person_10 (pilot_study)


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: two-person (pilot_study)

text: China:Wuhan

text: blood

text: Homo sapiens

text: two-person_11 (pilot_study)


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: two-person (pilot_study)

text: China:Wuhan

text: blood

text: Homo sapiens

text: two-person_12 (pilot_study)


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: two-person (pilot_study)

text: China:Wuhan

text: blood

text: Homo sapiens

text: two-person_13 (pilot_study)


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: two-person (pilot_study)

text: China:Wuhan

text: blood

text: Homo sapiens

text: two-person_14 (pilot_study)


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: two-person (pilot_study)

text: China:Wuhan

text: blood

text: Homo sapiens

text: two-person_15 (pilot_study)


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: two-person (pilot_study)

text: China:Wuhan

text: blood

text: Homo sapiens

text: two-person_16 (pilot_study)


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: two-person (pilot_study)

text: China:Wuhan

text: blood

text: Homo sapiens

text: two-person_17 (pilot_study)


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: two-person (pilot_study)

text: China:Wuhan

text: blood

text: Homo sapiens

text: two-person_18 (pilot_study)


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_1


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_2


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_3


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_4


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_5


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_6


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_7


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_8


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_9


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_10


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_11


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_12


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_13


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_14


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_15


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_16


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_17


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_18


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_19


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_20


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_21


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_22


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_23


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_24


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_25


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_26


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_27


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_28


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_29


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_30


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_31


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_32


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_33


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_34


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_35


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_36


text: live

text: MIGS/MIMS/MIMARKS.human-associated

text: MIGS.eu

text: single-source samples

text: China:Wuhan

text: blood

text: Homo sapiens

text: single-source samples_37